0001104659-21-154012.txt : 20211228 0001104659-21-154012.hdr.sgml : 20211228 20211228190416 ACCESSION NUMBER: 0001104659-21-154012 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211227 FILED AS OF DATE: 20211228 DATE AS OF CHANGE: 20211228 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Naftzger J. Christopher CENTRAL INDEX KEY: 0001496194 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37558 FILM NUMBER: 211525937 MAIL ADDRESS: STREET 1: 633 LOWTHER ROAD CITY: LEWISBERRY STATE: PA ZIP: 17339 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nabriva Therapeutics plc CENTRAL INDEX KEY: 0001641640 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 25-28 NORTH WALL QUAY CITY: DUBLIN STATE: L2 ZIP: D01 H104 BUSINESS PHONE: (610) 816-6640 MAIL ADDRESS: STREET 1: 414 COMMERCE DRIVE STREET 2: STE 120 CITY: FORT WASHINGTON STATE: PA ZIP: 19034 FORMER COMPANY: FORMER CONFORMED NAME: Nabriva Therapeutics AG DATE OF NAME CHANGE: 20150507 4 1 tm2136401-1_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2021-12-27 0 0001641640 Nabriva Therapeutics plc NBRV 0001496194 Naftzger J. Christopher 414 COMMERCE DR. SUITE 120 FORT WASHINGTON PA 19034 0 1 0 0 General Counsel and Corp Sec Ordinary Shares 2021-12-27 4 P 0 7000 0.59 A 7000 D /s/ Daniel Dolan, by power of attorney 2021-12-28